Results 181 to 190 of about 423,654 (300)

Impact of Leadless Pacemaker Implantation Position on Subclinical Right Ventricular Perforation

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Leadless pacemakers are typically implanted in the mid‐septum of the right ventricle (RV) to mitigate the risk of perforation. However, reports on the precise location of these implants are limited. This study aimed to elucidate tine‐based leadless pacemaker position and presence of subclinical RV perforation through computed ...
Young Shin Lee   +16 more
wiley   +1 more source

Werner Irnich: Pioneer in the Development of the Dual‐Chamber Pacemaker—An Obituary

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Fifty years ago, Werner Irnich presented the concept of an optimal pacemaker capable of responding appropriately to various cardiac arrhythmias and perceptual disturbances, and intended to be used in 85% of patients. With this concept, Irnich was far ahead of his time. His proposed circuitry for AV block and atrial fibrillation, as well as his
Bernd Lemke
wiley   +1 more source

Long‐Term Cardiovascular Outcomes Following New‐Onset Arrhythmias During Pregnancy

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Arrhythmias during pregnancy are increasingly prevalent and associated with acute adverse cardiovascular outcomes, yet their long‐term cardiovascular implications remain poorly defined. To address this gap, we conducted a large population‐based study to evaluate 5‐year cardiovascular outcomes following incident arrhythmias during ...
Sanya Dhama   +4 more
wiley   +1 more source

Safety and Performance of INVICTA DF4 Ventricular Defibrillation Lead: Results From APOLLO Prospective Multicenter Study

open access: yesPacing and Clinical Electrophysiology, EarlyView.
Abstract Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte   +13 more
wiley   +1 more source

Accounting for uncertainty in computational models of ventricular tachycardia improves ablation guidance. [PDF]

open access: yesNat Cardiovasc Res
Qadri AM   +12 more
europepmc   +1 more source

Navigating the Zero Fluoroscopy Frontier: Current Tools, Evidence and Future Directions in Electrophysiology Procedures

open access: yesPacing and Clinical Electrophysiology, EarlyView.
Graphical Abstract ABSTRACT Fluoroscopy has traditionally been the mainstay imaging technique for guidance during electrophysiology (EP) ablation procedures. The numerous disadvantages associated with radiation exposure for both operators and patients have created the need for zero‐fluoroscopy (ZF) approaches. Today, electrophysiologists have access to
Dimitrios Kotzadamis   +6 more
wiley   +1 more source

Ventricular Tachycardia or Not?: Decoding Post-Cardioversion Wide Complex Tachycardia in a CRT-D Patient. [PDF]

open access: yesJACC Case Rep
Kaiwan O   +6 more
europepmc   +1 more source

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh   +9 more
wiley   +1 more source

Impact of ICD Presence in Patients With Left Ventricular Assist Devices for End‐Stage Heart Failure

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The prognostic relevance of implantable cardioverter defibrillator (ICD) in patients with end‐stage heart failure (HF) with left ventricular assist device (LVAD) remains controversial. Objectives To evaluate the prognostic impact of ongoing use of ICD and associated complications in HF‐patients with LVAD‐implantation.
Nafilah Baridwan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy